Grant: Discovery Grants Program - Individual
Université Laval
$56,000.00
Smart Personalized Medical Platform for Cancer Diseases
FY 2024-25
Summary
This research proposal consists in the design of a new generation of an optical molecular imaging system embedded in an organ-on-chip system. The goal of the imaging system is to measure the neurotransmitter concentration in real time to understand the impact of cancer cells on the brain's neural network and the efficiency of commercialized anti-cancer drugs in the treatment of brain cancer cells. The sensor we are proposing is original in that it uses a functionalized and selective ultra-stable nanoparticle embedded in a high density microfluid micro-cavity array to image neurotransmitter concentration distribution when cancer cells grow in brain tissue from one side and from the other side ton investigate the efficiency of cancer drug. From a technological standpoint, the sensor is based on the hybrid integration of microfluidic/electronic/microelectronic, optic, MEMS technologies and nanoparticles in one single system.
We are especially interested in detecting the offset of the absorption shift of the functionalized ultra-stable gold nanoparticles with aptamers specific to neurotransmitters. Our goal is to be able to create a molecular imaging sensor using standard cameras. As such, it is the equivalent of the electronic lens of a microscope being able to detect molecular activity. The only way to currently observe molecules with optic lenses is by adding fluorophore markers. This involves the modification of the original solution and the loss of resolution, which is limited to 200 nm in most microscopes. The purpose of the system we are proposing to develop is to exceed this resolution limit by capturing the molecules with aptamers tied to the nanoparticles. This will modify the diameter of the molecule and thus absorption shift. Therefore, by detecting this shift, the neurotransmitter concentration can be determined. Our goal is to be able to detect the concentrations of at least two neurotransmitters (dopamine and ascorbic acid) in the order of the nanomoles at this stage of the research. We will also replicate the process for the serotonin, ?-aminobutyric acid, acetylcholine and glutamate neurotransmitters. We will therefore implement the first image sensor from selective gold nanoparticles for neurotransmitters. Such technology could be more widely used, beyond neuroscience, for example in the detection of drugs and water toxins.
Program
Discovery Grants Program - Individual
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
RGPIN-2020-06275
Name nom
Miled, Amine
Department département
Génie électrique et génie informatique - Génie électrique et génie informatique
Organization id
51
Institution établissement
Université Laval
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2020
Award amount
56000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1510
Committee name en
Electrical and Computer Engineering
Committee name fr
Génie électrique et informatique
Area of application code
1102
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Biomedical engineering
Area of application fr
Génie biomédical
Research subject code
2518
Research subject group en
Electrical and electronic engineering
Research subject group fr
Génie électrique et électronique
Research subject en
Instrumentation and measurements
Research subject fr
Instrumentation et mesures
Field of research list names en
Not available
Field of research list names fr
Non disponible
Socioeconomic objective list names en
Not available
Socioeconomic objective list names fr
Non disponible
Application title
Smart Personalized Medical Platform for Cancer Diseases
Keywords
personalized medicine; microfluidic; hybrid technologies; organ-on-chip; lab-on-chip; oncology; biosensor and actuator; on-chip cell growth; cell culture; real-time medical analysis
Application summary
This research proposal consists in the design of a new generation of an optical molecular imaging system embedded in an organ-on-chip system. The goal of the imaging system is to measure the neurotransmitter concentration in real time to understand the impact of cancer cells on the brain's neural network and the efficiency of commercialized anti-cancer drugs in the treatment of brain cancer cells. The sensor we are proposing is original in that it uses a functionalized and selective ultra-stable nanoparticle embedded in a high density microfluid micro-cavity array to image neurotransmitter concentration distribution when cancer cells grow in brain tissue from one side and from the other side ton investigate the efficiency of cancer drug. From a technological standpoint, the sensor is based on the hybrid integration of microfluidic/electronic/microelectronic, optic, MEMS technologies and nanoparticles in one single system.
We are especially interested in detecting the offset of the absorption shift of the functionalized ultra-stable gold nanoparticles with aptamers specific to neurotransmitters. Our goal is to be able to create a molecular imaging sensor using standard cameras. As such, it is the equivalent of the electronic lens of a microscope being able to detect molecular activity. The only way to currently observe molecules with optic lenses is by adding fluorophore markers. This involves the modification of the original solution and the loss of resolution, which is limited to 200 nm in most microscopes. The purpose of the system we are proposing to develop is to exceed this resolution limit by capturing the molecules with aptamers tied to the nanoparticles. This will modify the diameter of the molecule and thus absorption shift. Therefore, by detecting this shift, the neurotransmitter concentration can be determined. Our goal is to be able to detect the concentrations of at least two neurotransmitters (dopamine and ascorbic acid) in the order of the nanomoles at this stage of the research. We will also replicate the process for the serotonin, ?-aminobutyric acid, acetylcholine and glutamate neurotransmitters. We will therefore implement the first image sensor from selective gold nanoparticles for neurotransmitters. Such technology could be more widely used, beyond neuroscience, for example in the detection of drugs and water toxins.